長期投資家のためのIR情報
バリュートレンド

【4597】ソレイジア・ファーマ
創薬。がんに注力。大株主に伊藤忠商事。
類似企業:
【業界1位】 武田薬品工業
【売上同水準】 PRISM BioLab ステラファーマ

売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2025.12 2026/02/13 実 429 ↑ +7.3% -67.0% -861 ↑ +4.3% -32.5% -876 ↑ +2.7% -34.8% -876 ↑ +2.7% -34.8%
2025.12 2025/12/23 修正予 400 ↓ -69.2% -69.2% -900 ↓ -38.5% -38.5% -900 ↓ -38.5% -38.5% -900 ↓ -38.5% -38.5%
2025.12 2025/11/14 Q3予 1,300 → 0.0% 0.0% -650 → 0.0% 0.0% -650 → 0.0% 0.0% -650 → 0.0% 0.0%
2025.12 2025/08/13 Q2予 1,300 → 0.0% 0.0% -650 → 0.0% 0.0% -650 → 0.0% 0.0% -650 → 0.0% 0.0%
2025.12 2025/05/14 Q1予 1,300 → 0.0% 0.0% -650 → 0.0% 0.0% -650 → 0.0% 0.0% -650 → 0.0% 0.0%
2025.12 2025/02/12 当初予 1,300 - - - -650 - - - -650 - - - -650 - - -
2024.12 2025/02/12 実 316 ↑ +5.3% -77.0% -1,951 ↓ -85.8% -200.2% -1,961 ↓ -86.8% -190.5% -1,941 ↓ -84.9% -187.6%
2024.12 2025/01/06 修正予 300 ↑ +87.5% -78.2% -1,050 ↑ +8.7% -61.5% -1,050 ↑ +8.7% -55.6% -1,050 ↑ +8.7% -55.6%
2024.12 2024/12/27 修正予 160 ↓ -88.4% -88.4% -1,150 ↓ -70.4% -76.9% -1,150 ↓ -70.4% -70.4% -1,150 ↓ -70.4% -70.4%
2024.12 2024/11/13 Q3予 1,375 → 0.0% 0.0% -675 → 0.0% -3.8% -675 → 0.0% 0.0% -675 → 0.0% 0.0%
2024.12 2024/08/14 Q2予 1,375 → 0.0% 0.0% -675 → 0.0% -3.8% -675 → 0.0% 0.0% -675 → 0.0% 0.0%
2024.12 2024/05/15 Q1予 1,375 → 0.0% 0.0% -675 ↓ -3.8% -3.8% -675 → 0.0% 0.0% -675 → 0.0% 0.0%
2024.12 2024/02/14 当初予 1,375 - - - -650 - - - -675 - - - -675 - - -
2023.12 2024/02/14 実 617 ↓ -0.5% -55.9% -1,139 ↑ +1.0% -51.9% -1,135 ↑ +1.3% -51.3% -1,112 ↑ +3.3% -48.3%
2023.12 2023/12/28 修正予 620 ↓ -55.7% -55.7% -1,150 ↓ -53.3% -53.3% -1,150 ↓ -53.3% -53.3% -1,150 ↓ -53.3% -53.3%
2023.12 2023/11/13 Q3予 1,400 → 0.0% 0.0% -750 → 0.0% 0.0% -750 → 0.0% 0.0% -750 → 0.0% 0.0%
2023.12 2023/08/10 Q2予 1,400 → 0.0% 0.0% -750 → 0.0% 0.0% -750 → 0.0% 0.0% -750 → 0.0% 0.0%
2023.12 2023/05/15 Q1予 1,400 → 0.0% 0.0% -750 → 0.0% 0.0% -750 → 0.0% 0.0% -750 → 0.0% 0.0%
2023.12 2023/02/14 当初予 1,400 - - - -750 - - - -750 - - - -750 - - -
2022.12 2023/02/14 実 1,092 ↓ -5.0% -64.2% -2,470 ↓ -5.1% -420.0% -2,492 ↓ -4.9% -424.6% -2,548 ↓ -4.0% -343.1%
2022.12 2022/11/25 修正予 1,150 → 0.0% -62.3% -2,350 ↓ -9.3% -394.7% -2,375 ↓ -9.2% -400.0% -2,450 ↓ -8.9% -326.1%
2022.12 2022/11/14 Q3予 1,150 ↓ -62.3% -62.3% -2,150 ↓ -352.6% -352.6% -2,175 ↓ -357.9% -357.9% -2,250 ↓ -291.3% -291.3%
2022.12 2022/08/15 Q2予 3,050 → 0.0% 0.0% -475 → 0.0% 0.0% -475 → 0.0% 0.0% -575 → 0.0% 0.0%
2022.12 2022/05/13 Q1予 3,050 → 0.0% 0.0% -475 → 0.0% 0.0% -475 → 0.0% 0.0% -575 → 0.0% 0.0%
2022.12 2022/02/09 当初予 3,050 - - - -475 - - - -475 - - - -575 - - -
2021.12 2022/02/09 実 559 ↓ -6.8% -73.4% -2,419 ↑ +3.2% -5.2% -2,442 ↑ +2.3% -6.2% -2,478 ↑ +0.9% -7.7%
2021.12 2021/11/10 Q3予 600 ↓ -71.4% -71.4% -2,500 ↓ -8.7% -8.7% -2,500 ↓ -8.7% -8.7% -2,500 ↓ -8.7% -8.7%
2021.12 2021/08/11 Q2予 2,100 → 0.0% 0.0% -2,300 → 0.0% 0.0% -2,300 → 0.0% 0.0% -2,300 → 0.0% 0.0%
2021.12 2021/05/12 Q1予 2,100 → 0.0% 0.0% -2,300 → 0.0% 0.0% -2,300 → 0.0% 0.0% -2,300 → 0.0% 0.0%
2021.12 2021/02/10 当初予 2,100 - - - -2,300 - - - -2,300 - - - -2,300 - - -
2020.12 2021/02/10 実 454 ↑ +0.9% -63.7% -4,116 ↑ +2.0% -68.0% -4,159 ↑ +1.0% -69.8% -4,127 ↑ +1.7% -68.4%
2020.12 2020/12/15 修正予 450 ↓ -64.0% -64.0% -4,200 ↓ -71.4% -71.4% -4,200 ↓ -71.4% -71.4% -4,200 ↓ -71.4% -71.4%
2020.12 2020/11/13 Q3予 1,250 → 0.0% 0.0% -2,450 → 0.0% 0.0% -2,450 → 0.0% 0.0% -2,450 → 0.0% 0.0%
2020.12 2020/08/12 Q2予 1,250 → 0.0% 0.0% -2,450 → 0.0% 0.0% -2,450 → 0.0% 0.0% -2,450 → 0.0% 0.0%
2020.12 2020/05/14 Q1予 1,250 → 0.0% 0.0% -2,450 → 0.0% 0.0% -2,450 → 0.0% 0.0% -2,450 → 0.0% 0.0%
2020.12 2020/02/13 当初予 1,250 - - - -2,450 - - - -2,450 - - - -2,450 - - -
2019.12 2020/02/13 実 1,310 ↑ +19.1% +19.1% -1,762 ↑ +29.5% +29.5% -1,797 ↑ +28.1% +28.1% -1,867 ↑ +25.3% +25.3%
2019.12 2019/11/13 Q3予 1,100 → 0.0% 0.0% -2,500 → 0.0% 0.0% -2,500 → 0.0% 0.0% -2,500 → 0.0% 0.0%
2019.12 2019/08/14 Q2予 1,100 → 0.0% 0.0% -2,500 → 0.0% 0.0% -2,500 → 0.0% 0.0% -2,500 → 0.0% 0.0%
2019.12 2019/05/15 Q1予 1,100 → 0.0% 0.0% -2,500 → 0.0% 0.0% -2,500 → 0.0% 0.0% -2,500 → 0.0% 0.0%
2019.12 2019/02/13 当初予 1,100 - - - -2,500 - - - -2,500 - - - -2,500 - - -
2018.12 2019/02/13 実 318 ↓ -9.1% -9.1% -2,420 ↑ +21.9% +21.9% -2,445 ↑ +21.1% +21.1% -2,422 ↑ +21.9% +21.9%
2018.12 2018/11/14 Q3予 350 → 0.0% 0.0% -3,100 → 0.0% 0.0% -3,100 → 0.0% 0.0% -3,100 → 0.0% 0.0%
2018.12 2018/08/10 Q2予 350 → 0.0% 0.0% -3,100 → 0.0% 0.0% -3,100 → 0.0% 0.0% -3,100 → 0.0% 0.0%
2018.12 2018/05/15 Q1予 350 → 0.0% 0.0% -3,100 → 0.0% 0.0% -3,100 → 0.0% 0.0% -3,100 → 0.0% 0.0%
2018.12 2018/02/09 当初予 350 - - - -3,100 - - - -3,100 - - - -3,100 - - -
2017.12 2018/02/09 実 410 → 0.0% -3.1% -1,009 ↑ +8.3% +43.5% -1,016 ↑ +7.6% +43.3% -1,007 ↑ +8.5% +44.0%
2017.12 2017/12/22 修正予 410 ↓ -3.1% -3.1% -1,100 ↑ +38.4% +38.4% -1,100 ↑ +38.7% +38.7% -1,100 ↑ +38.8% +38.8%
2017.12 2017/11/14 Q3予 423 → 0.0% 0.0% -1,787 → 0.0% 0.0% -1,793 → 0.0% 0.0% -1,798 → 0.0% 0.0%
2017.12 2017/08/10 Q2予 423 → 0.0% 0.0% -1,787 → 0.0% 0.0% -1,793 → 0.0% 0.0% -1,798 → 0.0% 0.0%
2017.12 2017/05/15 当初予 423 - - - -1,787 - - - -1,793 - - - -1,798 - - -
シェア ツイート
ページトップへ戻る